Abstract
Patients with diabetes mellitus (DM) infected with COVID are at risk for developing severe complications including diabetic ketoacidosis (DKA) and/or hyperosmolar hyperglycemic state (HHS)1. They may have a more severe disease course and higher mortality compared to those without DM or hyperglycemia2. The Riverside University Health System Medical Center (RUHS-MC)-DKA Outcomes Group (RUDOG) initiated a study to determine causes and outcomes before and during the pandemic in patients hospitalized for DKA and/or HHS.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
